Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02934789Completed
Randomised, open-label trial in Submucosal Leiomyoma (2 arms), sponsored by All For Women Healthcare. Primary endpoint: Quality of life score at 2 years. Started Sep 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02934789.